Ginkgo Bioworks Holdings (DNA) Stock Forecast: StockMap's 2-Week Call

DNA stock forecast: StockMap's model makes no two-week call on Ginkgo Bioworks Holdings after the Nov 19 close: its evidence is split, 3 reasons for and 12 against. Right in 1 of 4 two-week windows on DNA since Aug 21; by chance, a call on the same dates was right 69% of the time.

Ginkgo Bioworks Holdings last closed at $8.20, -2.84% on the session.

Against the IVW growth benchmark the position is -0.51% over the forecast window.

Ginkgo Bioworks Holdings' market cap is $506.98M as of November 19, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 3 (too close to call).

Where DNA sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 20%.

28 daily calls for DNA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Ginkgo Bioworks Holdings in the 16th percentile on return on equity, where 100 is best.

Ginkgo Bioworks Holdings is classified under Health Care / Life Sciences Tools & Services.

StockMap tracks Ginkgo Bioworks Holdings as the 35th largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 23 Neutral, 16 Moderate Outperform and 3 Moderate Underperform.

On that composite Ginkgo Bioworks Holdings ranks 31st of 42 in the group, against a group median of +0.13.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Ginkgo Bioworks Holdings (DNA) — StockMap 2-week forecast & tracked accuracy